From lipid signatures to cellular responses: unraveling the complexity of melanoma and furthering its diagnosis and treatment

Recent advancements in mass spectrometry have significantly enhanced our understanding of complex lipid profiles, opening new avenues for oncological diagnostics. This review highlights the importance of lipidomics in the comprehension of certain metabolic pathways and its potential for the detectio...

ver descrição completa

Detalhes bibliográficos
Autores: Díaz Grijuela, Elisa, Hernández, Agustín, Caballero, Claudia, Fernández, Roberto, Urtasun Alonso, Raquel, Gulak, Marina, Astigarraga, Egoitz, Barajas Vélez, Miguel Ángel, Barreda-Gómez, Gabriel
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Recursos:Universidad San Jorge (USJ)
Repositorio:Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
OAI Identifier:oai:academica-e.unavarra.es:2454/52140
Acesso em linha:https://hdl.handle.net/2454/52140
Access Level:acceso abierto
Palavra-chave:Comparative oncology
Lipidomics
Liquid biopsy
Mass spectrometry
Melanoma
Descrição
Resumo:Recent advancements in mass spectrometry have significantly enhanced our understanding of complex lipid profiles, opening new avenues for oncological diagnostics. This review highlights the importance of lipidomics in the comprehension of certain metabolic pathways and its potential for the detection and characterization of various cancers, in particular melanoma. Through detailed case studies, we demonstrate how lipidomic analysis has led to significant breakthroughs in the identification and understanding of cancer types and its potential for detecting unique biomarkers that are instrumental in its diagnosis. Additionally, this review addresses the technical challenges and future perspectives of these methodologies, including their potential expansion and refinement for clinical applications. The discussion underscores the critical role of lipidomic profiling in advancing cancer diagnostics, proposing a new paradigm in how we approach this devastating disease, with particular emphasis on its application in comparative oncology.